Calcium Antagonists in the Treatment of Individuals with Ischemic Heart Disease

The so-called calcium antagonists—verapamil, nifedipine, diltiazem, and perhexiline—are pharmacologic agents that will have a dramatic impact on the medical therapy of individuals with ischemic heart disease. They have been used extensively in Europe and Japan for over 15 years, and more recent studies from this country have demonstrated their efficacy in the treatment of patients with Prinzmetal's "variant" angina pectoris, stable (exertional) an gina pectoris, and unstable angina pectoris. In addition, they appear effective in protecting ischemic myocardium both in patients with acute myocardial infarction as well as in those undergoing cardiopulmonary bypass. The purpose of this review is twofold: (a) to describe the mechanism of action and phar macology of these agents and (b) to delineate their role in the treatment of individuals with ischemic heart disease.

[1]  S. Nitter‐Hauge,et al.  Effect of nifedipine (Adalat) on coronary haemodynamics in patients with coronary arteriosclerotic disease. , 2009, Acta medica Scandinavica.

[2]  E. Raftery,et al.  Randomized double-blind comparison of verapamil and nifedipine in chronic stable angina. , 1982, The American journal of cardiology.

[3]  J. Corbett,et al.  Double-blind, randomized, placebo-controlled comparison of propranolol and verapamil in the treatment of patients with stable angina pectoris. , 1981, The American journal of medicine.

[4]  R. Bonow,et al.  Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration. , 1981, The American journal of cardiology.

[5]  M. Bowles,et al.  Long-term antianginal action of verapamil assessed with quantitated serial treadmill stress testing. , 1981, The American journal of cardiology.

[6]  W. Freeman,et al.  Verapamil therapy in variant angina pectoris refractory to nitrates. , 1981, American heart journal.

[7]  R. Bonow,et al.  Clinical efficacy of verapamil alone and combined with propranolol in treating patients with chronic stable angina pectoris. , 1981, The American journal of cardiology.

[8]  D. Kelly,et al.  Coronary Artery Spasm During Exercise: Treatment with Verapamil , 1981, Circulation.

[9]  D. Waters,et al.  Provocative testing with ergonovine to assess the efficacy of treatment with nifedipine, diltiazem and verapamil in variant angina. , 1981, The American journal of cardiology.

[10]  J. Corbett,et al.  Effect of verapamil and nifedipine on left ventricular function at rest and during exercise in patients with Prinzmetal's variant angina pectoris. , 1981, The American journal of cardiology.

[11]  L. Hillis,et al.  Comparison of verapamil and nifedipine in the treatment of variant angina pectoris: preliminary observations in 10 patients. , 1981, The American journal of cardiology.

[12]  C. Conti,et al.  Effect of diltiazem in patients with variant angina: a randomized double-blind trial. , 1981, American heart journal.

[13]  L. Hillis,et al.  A controlled trial of verapamil for Prinzmetal's variant angina. , 1981, The New England journal of medicine.

[14]  H. Kishida,et al.  Treatment of Variant Angina with Drugs: A Survey of 11 Cardiology Institutes in Japan , 1981, Circulation.

[15]  J. Moses,et al.  Efficacy of nifedipine in rest angina refractory to propranolol and nitrates in patients with obstructive coronary artery disease. , 1981, Annals of internal medicine.

[16]  J. Muller,et al.  Prevention by Nifedipine of Abnormal Coronary Vasoconstriction in Patients with Coronary Artery Disease , 1981, Circulation.

[17]  R. Corbalán,et al.  Effect of a calcium inhibitor, nifedipine, on exercise tolerance in patients with angina pectoris: a double-blind study. , 1981, Chest.

[18]  J. Ferlinz,et al.  Antianginal and myocardial metabolic properties of verapamil in coronary artery disease. , 1980, The American journal of cardiology.

[19]  D. Baim,et al.  Efficacy of diltiazem for control of symptoms of coronary arterial spasm. , 1980, The American journal of cardiology.

[20]  L. Opie,et al.  Adverse interaction between nifedipine and beta-blockade. , 1980, British medical journal.

[21]  R. Sung,et al.  Intravenous verapamil for termination of re-entrant supraventricular tachycardias: intracardiac studies correlated with plasma verapamil concentrations. , 1980, Annals of internal medicine.

[22]  E. Prystowsky,et al.  Effects of Intravenous and Chronic Oral Verapamil Administration in Patients with Supraventricular Tachyarrhythmias , 1980, Circulation.

[23]  E. Braunwald,et al.  Autoradiographic method for measuring the ischemic myocardium at risk: effects of verapamil on infarct size aftr experimental coronary artery occlusion. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Verani,et al.  Exercise-induced coronary arterial spasm: angiographic demonstration, documentation of ischemia by myocardial scintigraphy and results of pharmacologic intervention. , 1980, The American journal of cardiology.

[25]  W. Nayler,et al.  Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium. , 1980, The American journal of cardiology.

[26]  H. Dargie,et al.  Objective assessment of antianginal treatment: a double-blind comparison of propranolol, nifedipine, and their combination. , 1980, British medical journal.

[27]  R. Casteels.  Electro- and pharmacomechanical coupling in vascular smooth muscle. , 1980, Chest.

[28]  M. Nakamura,et al.  Myocardial blood flow following experimental coronary occlusion. Effects of diltiazem. , 1980, Chest.

[29]  E. Antman,et al.  Nifedipine therapy for coronary-artery spasm. Experience in 127 patients. , 1980, The New England journal of medicine.

[30]  M. Kaltenbach,et al.  Treatment of hypertrophic obstructive cardiomyopathy with verapamil , 1980, British heart journal.

[31]  L. Tavazzi,et al.  Treatment of angina at rest with nifedipine: a short-term controlled study. , 1980, The American journal of cardiology.

[32]  R. Chahine,et al.  The effectiveness of combined verapamil and nitrate therapy in Prinzmetal's variant angina , 1980 .

[33]  K. Ng.  Asystole after verapamil and digoxin. , 1980 .

[34]  L. Décourt,et al.  Effect of verapamil on regional coronary and myocardial perfusion during acute coronary occlusion. , 1980, The American journal of cardiology.

[35]  B. Maron,et al.  Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects. , 1979, Circulation.

[36]  R. E. Clark,et al.  Nifedipine: a myocardial protective agent. , 1979, The American journal of cardiology.

[37]  F. Heupler,et al.  Nifedipine therapy for refractory coronary arterial spasm. , 1979, The American journal of cardiology.

[38]  R. E. Clark,et al.  Effect of nifedipine on myocardial ischemia: analysis of collateral flow, pulsatile heat and regional muscle shortening. , 1979, The American journal of cardiology.

[39]  M. Kaltenbach,et al.  Effects of nifedipine after intravenous and intracoronary administration. , 1979, The American journal of cardiology.

[40]  S. Chierchia,et al.  Significance of spasm in the pathogenesis of ischemic heart disease. , 1979, The American journal of cardiology.

[41]  R. Zelis,et al.  Nifedipine therapy for stable angina pectoris: preliminary results of effects on angina frequency and treadmill exercise response. , 1979, The American journal of cardiology.

[42]  J. Kastor,et al.  Nifedipine in the treatment of Prinzmetal's (variant) angina. , 1979, The American journal of cardiology.

[43]  D. Hathaway,et al.  Role of calcium and cyclic adenosine 3':5' monophosphate in regulating smooth muscle contraction. Mechanisms of excitation-contraction coupling in smooth muscle. , 1979, The American journal of cardiology.

[44]  D. Waters,et al.  Provocative Testing with Ergonovine to Evaluate the Efficacy of Treatment with Calcium Antagonists in Variant Angina , 1979, Circulation.

[45]  M. Nakamura,et al.  Beneficial effect of diltiazem, a new antianginal drug, on angina pectoris at rest. , 1979, Japanese heart journal.

[46]  D. Krikler,et al.  Effect of nifedipine on atrioventricular conduction as compared with verapamil. Intracardiac electrophysiological study. , 1979, British heart journal.

[47]  V. Gott,et al.  Comparison of Myocardial Protection with Nifedipine and Potassium , 1979, Circulation.

[48]  G. Ciliberto,et al.  Comparative effects of nifedipine, verapamil, isosorbide dinitrate and propranolol on exercise-induced angina pectoris. , 1979, British journal of clinical practice. Supplement.

[49]  R. Bing,et al.  Effect of diltiazem, a calcium antagonist, on myocardial ischemia. , 1979, The American journal of cardiology.

[50]  M. Olivari,et al.  Treatment of Hypertension with Nifedipine, A Calcium Antagonistic Agent , 1979, Circulation.

[51]  M. Olivari,et al.  Clinical use of a calcium antagonistic agent (nifedipine) in acute pulmonary edema. , 1979, The American journal of medicine.

[52]  H. Yasue,et al.  Exertional angina pectoris caused by coronary arterial spasm: effects of various drugs. , 1979, British journal of clinical practice. Supplement.

[53]  A. Maseri,et al.  Management of unstable angina at rest by verapamil. A double-blind cross-over study in coronary care unit. , 1979, British heart journal.

[54]  W. Aronow,et al.  Effects of verapamil on myocardial performance in coronary disease. , 1979, Circulation.

[55]  Kenmure Ac,et al.  A double-blind controlled trial of the anti-anginal efficacy of nifedipine compared with propranolol. , 1979, British journal of clinical practice. Supplement.

[56]  K. Fox,et al.  The Effects of Nifedipine on Acute Experimental Myocardial Ischemia and Infarction in Dogs , 1979, Circulation research.

[57]  H. Carrasco,et al.  Effect of verapamil on normal sinoatrial node function and on sick sinus syndrome. , 1978, American heart journal.

[58]  P. Poole‐Wilson,et al.  The effect of β-adrenoceptor and Ca2+ antagonist drugs on the hypoxia-induced increase in resting tension , 1978 .

[59]  A. Wechsler,et al.  Effects of Verapamil on Myocardial Tolerance to Ischemic Arrest: Comparison to Potassium Arrest , 1978, Circulation.

[60]  M. Mir,et al.  Assessment of perhexiline maleate in angiographically proven intractable angina: A double-blind trial , 1978 .

[61]  J. Shaver,et al.  Pressure and sound correlates of the mitral valve ecyocardiogram in mitral stenosis. , 1978, Circulation.

[62]  J. Hansen,et al.  Treatment of Prinzmetal's angina due to coronary artery spasm using verapamil: a report of three cases. , 1978, European journal of cardiology.

[63]  A. Jariwalla,et al.  Production of ischaemic cardiac pain by nifedipine. , 1978, British medical journal.

[64]  Solberg Le,et al.  Prinzmetal's variant angina--response to verapamil. , 1978 .

[65]  W. Nayler,et al.  Pharmacological protection of mitochondrial function in hypoxic heart muscle: Effect of verapamil, propranolol, and methylprednisolone. , 1978, Cardiovascular research.

[66]  H. Yasue,et al.  Pathogenesis and treatment of angina pectoris at rest as seen from its response to various drugs. , 1978, Japanese circulation journal.

[67]  J. Muller,et al.  Nifedipine Therapy for Prinzmetal's Angina , 1978, Circulation.

[68]  Bramahn . Singh,et al.  Effects of intravenous verapamil on hemodynamics in patients with heart disease. , 1977, American heart journal.

[69]  K. Kohno,et al.  Pharmacokinetics and bioavailability of diltiazem (CRD-401) in dog. , 1977, Arzneimittel-Forschung.

[70]  P. Garlick,et al.  Ischemic contracture of the myocardium: mechanisms and prevention. , 1977, The American journal of cardiology.

[71]  G. Mcdonald.  LIVER DAMAGE AFTER PERHEXILINE MALEATE , 1977, The Lancet.

[72]  R. M. Mills,et al.  Reflex increase in coronary vascular resistance in patients with ischemic heart disease. , 1976, The New England journal of medicine.

[73]  W. Nayler,et al.  A protective effect of verapamil on hypoxic heart muscle. , 1976, Cardiovascular research.

[74]  J. Griffith,et al.  Regional Contractility: Selective Depression of Ischemic Myocardium by Verapamil , 1976, Circulation.

[75]  M. Eichelbaum,et al.  Physiological disposition of verapamil in man. , 1976, Cardiovascular research.

[76]  A. Pichard,et al.  Coronary arterial spasm in Prinzmetal's angina: a proved hypothesis. , 1976, The American journal of cardiology.

[77]  P. Bouche,et al.  [Peripheral neuropathies caused by perhexiline maleate. Apropos of 7 cases]. , 1976, Coeur et medecine interne.

[78]  K. Wrogemann,et al.  MITOCHONDRIAL CALCIUM OVERLOAD: A GENERAL MECHANISM FOR CELL-NECROSIS IN MUSCLE DISEASES , 1976, The Lancet.

[79]  M. Endo,et al.  Prinzmetal's Variant Form of Angina Pectoris: Re‐evaluation of Mechanisms , 1975, British journal of clinical practice. Supplement.

[80]  B. Singh,et al.  Effects of verapamil on infarct size following experimental coronary occlusion. , 1975, Cardiovascular research.

[81]  D. Zipes,et al.  Role of the slow current in cardiac electrophysiology. , 1975, Circulation.

[82]  E. Sowton,et al.  The effect of Verapamil on the cardiac conduction system in man , 1974 .

[83]  D. E. Potts,et al.  Coronary arterial spasm in Prinzmetal angina. Documentation by coronary arteriography. , 1973, The New England journal of medicine.

[84]  B. Livesley,et al.  Double-blind Evaluation of Verapamil, Propranolol, and Isosorbide Dinitrate against a Placebo in the Treatment of Angina Pectoris , 1973, British medical journal.

[85]  W. Nayler,et al.  Effect of verapamil on contractility, oxygen utilization, and calcium exchangeability in mammalian heart muscle. , 1972, Cardiovascular research.

[86]  R. W. Brower,et al.  Nifedipine in the treatment of unstable angina, coronary spasm and myocardial ischemia. , 1981, The American journal of cardiology.

[87]  K. Hossack,et al.  Improved exercise performance in persons with stable angina pectoris receiving diltiazem. , 1981, The American journal of cardiology.

[88]  B. Maron,et al.  Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. , 1980, Clinical and investigative medicine. Medecine clinique et experimentale.

[89]  M. A. Matlib,et al.  Effects of diltiazem, a calcium antagonist, on regional myocardial function and mitochondria after brief coronary occlusion. , 1980, Journal of molecular and cellular cardiology.

[90]  G. Cocco,et al.  Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia. , 1980, British journal of clinical practice. Supplement.

[91]  Bramahn . Singh,et al.  New perspectives in the pharmacologic therapy of cardiac arrhythmias. , 1980, Progress in cardiovascular diseases.

[92]  J. Hansen,et al.  Verapamil in acute myocardial infarction. , 1980, Clinical and investigative medicine. Medecine clinique et experimentale.

[93]  G. Lombardi,et al.  Effect of verapamil on ST-segment elevation evaluated by the orthogonal leads of the Frank vector system in patients with acute myocardial infarction. , 1980, Arzneimittel-Forschung.

[94]  A. Fabiato,et al.  Calcium and cardiac excitation-contraction coupling. , 1979, Annual review of physiology.

[95]  M. Abe,et al.  Effect of diltiazem on coronary hemodynamics and its clinical significance. , 1979, Japanese Heart Journal.

[96]  A. Kenmure,et al.  A double-blind controlled trial of the anti-anginal efficacy of nifedipine compared with propranolol. , 1979, The British journal of clinical practice.

[97]  R. Vlietstra,et al.  Prinzmetal's variant angina--response to verapamil. , 1978, Mayo Clinic proceedings.

[98]  P. Poole‐Wilson,et al.  The effect of beta-adrenoceptor and Ca2+ antagonist drugs on the hypoxia-induced increased in resting tension. , 1978, Cardiovascular research.

[99]  A. Fleckenstein.  Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. , 1977, Annual review of pharmacology and toxicology.

[100]  P. Maiolino,et al.  Hemodynamic effects caused by i.v. administration of verapamil in healthy subjects. , 1976, Arzneimittel-Forschung.

[101]  F. Horster.  Pharmacokinetics of Nifedipine-14C in Man , 1975 .

[102]  S. Motomura,et al.  Experimental Pharmacological Investigations of Effects of Nifedipine on Atrioventricular Conduction in Comparison with Those of Other Coronary Vasodilators , 1975 .

[103]  J. Newberne.  Proceedings: Assessment of safety data from patients on short and long-term perhexiline therapy. , 1973, Postgraduate medical journal.

[104]  G. Lazarov,et al.  [Prinzmetal's variant form of angina pectoris]. , 1973, Vutreshni bolesti.

[105]  T. Whitsett,et al.  Proceedings: A controlled study of the diuretic and natriuretic properties of perhexiline maleate in normal human volunteers. , 1973, Postgraduate medical journal.